U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H34O4
Molecular Weight 374.5137
Optical Activity UNSPECIFIED
Defined Stereocenters 8 / 8
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DIGITOXIGENIN

SMILES

[H][C@]12CC[C@]3([H])[C@]([H])(CC[C@]4(C)[C@H](CC[C@]34O)C5=CC(=O)OC5)[C@@]1(C)CC[C@H](O)C2

InChI

InChIKey=XZTUSOXSLKTKJQ-CESUGQOBSA-N
InChI=1S/C23H34O4/c1-21-8-5-16(24)12-15(21)3-4-19-18(21)6-9-22(2)17(7-10-23(19,22)26)14-11-20(25)27-13-14/h11,15-19,24,26H,3-10,12-13H2,1-2H3/t15-,16+,17-,18+,19-,21+,22-,23+/m1/s1

HIDE SMILES / InChI

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/29101813 | https://www.ncbi.nlm.nih.gov/pubmed/28303962 | https://www.ncbi.nlm.nih.gov/pubmed/16081050 | https://www.ncbi.nlm.nih.gov/pubmed/13873586

Digitoxigenin is a cardenolide and aglycone constituent of digitoxin, an extract from the foxglove plant, D. purpurea. It elicits cardiac contraction and cardiotonic effects by inhibiting the Na+/K+ ATPase via binding at the digitalis receptor site with nanomolar potency. Digitoxigenin is highly cytotoxic, inhibiting Na+/K+ ATPase-dependent protein synthesis, and has been examined for use as an antitumor compound.

Originator

Sources: Berichte der Deutschen Chemischen Gesellschaft (1918), 51, 1613-39.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells.
2001 Jun
Defective activity and isoform of the Na,K-ATPase in the dilated cardiomyopathic hamster.
2001 Mar
Structure-based design and synthesis of novel potent Na+,K+ -ATPase inhibitors derived from a 5alpha,14alpha-androstane scaffold as positive inotropic compounds.
2003 Aug 14
[Study of the relation between the electromolecular characteristics of digitalis compounds and their pharmacological action].
2003 Jan-Mar
Structural mechanism of specific ligand recognition by a lipocalin tailored for the complexation of digoxigenin.
2003 Jul 4
Constituents of the Vietnamese medicinal plant Streptocaulon juventas and their antiproliferative activity against the human HT-1080 fibrosarcoma cell line.
2003 Nov
Determination of strophanthidin in ingesta and plant material by LC-MS/MS.
2004 Apr 21
Enhancement of ligand-dependent vitamin D receptor transactivation by the cardiotonic steroid bufalin.
2005 Nov 15
A new antihypertensive agent that antagonizes the prohypertensive effect of endogenous ouabain and adducin.
2006 Jan
De novo approach to 2-deoxy-beta-glycosides: asymmetric syntheses of digoxose and digitoxin.
2007 Mar 30
[Chemical constituents of Periploca forrestii].
2009 Dec
Cardiac glycosides induce cell death in human cells by inhibiting general protein synthesis.
2009 Dec 16
Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
2009 Oct 27
Inhibitory activity of a phytochemically characterized fraction from Streptocaulon juventas on lung cancer in nude mice.
2010 Apr
Electrophysiological characterization of ATPases in native synaptic vesicles and synaptic plasma membranes.
2010 Mar 15
A cardiac glucoside with in vitro anti-HIV activity isolated from Elaeodendron croceum.
2010 Nov
Acute cardiac toxicity of nerium oleander/indicum poisoning (kaner) poisoning.
2010 Oct
12β,14-Dihy-droxy-3-oxo-5β,20(22)-cardenolide monohydrate.
2010 Oct 2
Patents

Sample Use Guides

LD50 (cat) = 0.6mg/kg LD50 (guinea-pig) = 2,65 mg/kg
Route of Administration: Intravenous
The effects of ouabain, digitoxigenin, and INCICH-D7 were determined in the standard reaction medium at different concentrations (0.1 nM–1 mM). The enzyme (7 mkg/ml) was preincubated for 10 min at 37 C in the reaction medium with ouabain, digitoxigenin or INCICH-D7. The reaction was started by adding ATP (2.5 mM), lasted for 10 min, and stopped by adding an equal volume of 10% iced-cold trichloroacetic acid. The tubes were then centrifuged at 3000 rpm for 5 min. The hydrolyzed ATP was measured by determining inorganic phosphate (Pi) released according to the method of Taussky and Shorr
Name Type Language
DIGITOXIGENIN
MI  
Common Name English
CERBERIGENIN
Common Name English
CARD-20(22)-ENOLIDE, 3,14-DIHYDROXY-, (3.BETA.,5.BETA.)-
Common Name English
(+)-DIGITOXIGENIN
Common Name English
NSC-407806
Code English
.DELTA.20:22-3,14,21-TRIHYDROXYNORCHOLENIC ACID LACTONE
Common Name English
DIGITOXIGENIN [MI]
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID80162276
Created by admin on Sat Dec 16 08:31:26 GMT 2023 , Edited by admin on Sat Dec 16 08:31:26 GMT 2023
PRIMARY
ECHA (EC/EINECS)
205-603-4
Created by admin on Sat Dec 16 08:31:26 GMT 2023 , Edited by admin on Sat Dec 16 08:31:26 GMT 2023
PRIMARY
WIKIPEDIA
Digitoxigenin
Created by admin on Sat Dec 16 08:31:26 GMT 2023 , Edited by admin on Sat Dec 16 08:31:26 GMT 2023
PRIMARY
FDA UNII
S63WOD4VOL
Created by admin on Sat Dec 16 08:31:26 GMT 2023 , Edited by admin on Sat Dec 16 08:31:26 GMT 2023
PRIMARY
PUBCHEM
4369270
Created by admin on Sat Dec 16 08:31:26 GMT 2023 , Edited by admin on Sat Dec 16 08:31:26 GMT 2023
PRIMARY
DRUG BANK
DB04177
Created by admin on Sat Dec 16 08:31:26 GMT 2023 , Edited by admin on Sat Dec 16 08:31:26 GMT 2023
PRIMARY
NSC
407806
Created by admin on Sat Dec 16 08:31:26 GMT 2023 , Edited by admin on Sat Dec 16 08:31:26 GMT 2023
PRIMARY
MERCK INDEX
m4451
Created by admin on Sat Dec 16 08:31:26 GMT 2023 , Edited by admin on Sat Dec 16 08:31:26 GMT 2023
PRIMARY Merck Index
CAS
143-62-4
Created by admin on Sat Dec 16 08:31:26 GMT 2023 , Edited by admin on Sat Dec 16 08:31:26 GMT 2023
PRIMARY
CHEBI
42219
Created by admin on Sat Dec 16 08:31:26 GMT 2023 , Edited by admin on Sat Dec 16 08:31:26 GMT 2023
PRIMARY